Menestret P, Corbineau H, Langanay T, Valla J, Gouezec H, Sellin M, Le Couls H, Leguerrier A, Logeais Y, Mallédant Y
Service d'Anesthésie, Réanimation Chirurgicale, CHRU Pontchaillou, Rennes.
Cah Anesthesiol. 1996;44(1):49-54.
In cardiac surgery, blood retransfusion from the thoracic drainages, though already ancient, still remains controversial either for its quantitative or its qualitative interests. A retrospective study has been conducted, between the 1st january 1992 and the 30th june 1993, over 1.655 consecutive operations. Most of the patients suffered from coronary disease (937) or a valvular disease (605), others had been operated for a combined valvular and coronary revascularization surgery (113). The safety of this technique, guaranteed by strict rules, allowed a "transfusional strategy" which tends to reduce the homologous blood consumption. Twenty-nine percent of all the patients received homologous red cells units and only 23% of the patients operated for a coronary revascularization. This strategy aims to reduce both the risks of blood transfusion and the health cost.
在心脏外科手术中，尽管从胸腔引流液中回输血这一做法由来已久，但无论从其数量还是质量方面考量，仍存在争议。1992年1月1日至1993年6月30日期间，对连续进行的1655例手术开展了一项回顾性研究。大多数患者患有冠心病（937例）或瓣膜病（605例），其他患者则接受了瓣膜和冠状动脉血运重建联合手术（113例）。该技术的安全性通过严格规则得以保障，从而形成了一种旨在减少同源血消耗的“输血策略”。所有患者中有29%接受了同源红细胞单位输血，而接受冠状动脉血运重建手术的患者中只有23%输血。这一策略旨在降低输血风险和医疗成本。
